• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORGANON & CO. JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORGANON & CO. JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Insufficient Information (4580); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/14/2022
Event Type  Injury  
Manufacturer Narrative
Based on the information we have received, there is no indication that the device malfunctioned.The device is assembled according to specifications.In process and finished product testing are performed and approved prior to release.
 
Event Description
The provider did not place it properly, placed it way up in the fundus and then pulled it out [wrong technique in device usage process].Case narrative: this spontaneous report originating from united states was received from clinical educator (ce) via clinical educator (also reported as nurse), referring to a female patient of unknown age.The patient's medical history, concurrent conditions, past drugs/allergies, and concomitant medications were not reported.This report concerns 1 patient and 1 device.On an unknown date the patient used vacuum-induced hemorrhage control system (jada system) for single use (lot # was not reported) for an unknown indication.Reporter stated that clinical educator (ce) at the hospital reported to ce last night, (b)(6) 2014, that "the provider did not place it properly, placed it way up in the fundus and then pulled it out (wrong technique in device usage process).One was used and wasted because he did not use it the way he was trained." no further information available, no additional adverse event (ae) reported, no product quality compliant (pqc) reported.Medical attention was sought for the event.The availability of the vacuum-induced hemorrhage control system (jada system) for evaluation was unknown.Upon internal review the event wrong technique in device usage process was considered medically significant.Fda code: (health effects - health impact per annex f): (b)(4).
 
Manufacturer Narrative
Based on the information we have received, there is no indication that the device malfunctioned.The device is assembled according to specifications.In process and finished product testing are performed and approved prior to release.
 
Event Description
The provider did not place it properly, placed it way up in the fundus and then pulled it out [wrong technique in device usage process].Case narrative: this spontaneous report originating from united states was received from clinical educator (ce) via clinical educator (also reported as nurse), referring to a female patient of unknown age.The patient's medical history, concurrent conditions, past drugs/allergies, and concomitant medications were not reported.This report concerns 1 patient and 1 device.On an unknown date, the patient used vacuum-induced hemorrhage control system (jada system) for single use (lot # was not reported) for an unknown indication.Reporter stated that clinical educator (ce) at the hospital reported to ce last night, ((b)(6) 2022), that "the provider did not place it properly, placed it way up in the fundus and then pulled it out (wrong technique in device usage process).One was used and wasted because he did not use it the way he was trained." no further information available, no additional adverse event (ae) reported, no product quality compliant (pqc) reported.Medical attention was sought for the event.The availability of the vacuum-induced hemorrhage control system (jada system) for evaluation was unknown.Upon internal review the event wrong technique in device usage process was considered medically significant.Fda code: (health effects - health impact per annex f): 2199 no health consequences or impact (no apparent harm occurred in relation to the adverse event) follow up information was received from the physician on (b)(6) 2022.The physician had never used the device and her name was not reported correctly.She had received training but has not used the device and explained the reporter gave her information incorrectly.Medical device reporting criteria: serious injury.Fda code: (health effects - health impact per annex f): 4641 unexpected medical intervention.Patient required an unforeseen medical intervention, excluding surgery, which was not on the original treatment plan.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JADA SYSTEM
Type of Device
INTRAUTERINE VACUUM CONTRACTION SYSTEM
Manufacturer (Section D)
ORGANON & CO.
30 hudson street
jersey city NJ 07302
Manufacturer (Section G)
ORGANON & CO.
30 hudson street
jersey city NJ 07302
Manufacturer Contact
30 hudson street
jersey city, NJ 07302
MDR Report Key16033826
MDR Text Key305988658
Report Number3002806821-2022-00030
Device Sequence Number1
Product Code OQY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
510K K201199
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 01/02/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/22/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient SexFemale
-
-